Literature DB >> 15625260

Failed spinal anesthesia after a psoas compartment block.

Scott A Lang1, Chris Prusinkiewicz, Ban C H Tsui.   

Abstract

PURPOSE: To report the case of a patient who experienced failed spinal anesthesia following a psoas compartment block (PCB) and discuss its implications. CLINICAL FEATURES: A 70-yr-old male was scheduled for a right total hip arthroplasty. He agreed to a PCB for postoperative analgesia and a spinal anesthetic. The spinal anesthetic was performed after completion of the PCB. Free flow of clear fluid was demonstrated at the beginning and at the end of the presumed intrathecal injection. General anesthesia had to be induced because of failure of the spinal anesthetic. The patient awoke from his general anesthetic with a functional PCB and no evidence of residual neuraxial anesthesia. The possibility of epidural spread of local anesthetic from the PCB impairing the ability to perform spinal anesthesia is discussed and reviewed. We hypothesize that local anesthetic in the epidural space may have falsely reassured the anesthesiologist that the needle was properly placed.
CONCLUSION: We describe a case of failed spinal anesthesia following a PCB and discuss its implications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15625260     DOI: 10.1007/BF03018584

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  2 in total

1.  Evaluation of failed and high blocks associated with spinal anesthesia for Cesarean delivery following inadequate labour epidural: a retrospective cohort study.

Authors:  Lisa M Einhorn; Ashraf S Habib
Journal:  Can J Anaesth       Date:  2016-07-15       Impact factor: 6.713

2.  Comparison of lumbar plexus block using the short axis in-plane method at the plane of the transverse process and at the articular process: a randomized controlled trial.

Authors:  Rui Lu; Chengcheng Shen; Chunyong Yang; Yan Chen; Juanjuan Li; Kaizhi Lu
Journal:  BMC Anesthesiol       Date:  2018-02-07       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.